AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (565.8 KB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Article | Open Access

Cloning, Expression, Monoclonal Antibody Preparation of Human Gene NBEAL1 and Its Application in Targeted Imaging of Mouse Glioma

Chenchen Bao1,2Hao Yang2Ping Sheng1Juxiang Chen1Hua Song2Xuehua Ding1Bin Liu2Yicheng Lu1Guohan Hu1( )Daxiang Cui2( )
Department of Neurosurgery, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China
Department of Bio-Nano Science and Engineering, National Key Laboratory of Nano/Micro Fabrication Technology, Key Laboratory for Thin Film and Microfabrication of Ministry of Education, Institute of Micro-Nano Science and Technology, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai 200240, China
Show Author Information

Abstract

Human Neurobeachin-like 1(NBEAL1) gene was an important member of BEACH-WD40 domain family, which was confirmed to be overexpressed in Ⅰ stage glioma. In this study, we extracted total RNAs from U251 cell line, acquired its cDNA sequence by RT-PCR, and cloned part of NBEAL1 cDNA fragments into the vector pGEX-KG. The recombinant expression vector achieved high expression in E.coli BL21 as a GST fusion protein. NBEAL1 recombinant protein was purified by affinity chromatography. Monoclonal antibody was prepared against the recombinant NBEAL1 protein. Its bioactivity was identified by Western Blotting analysis. Anti-NBEAL1 antibody was conjugated with CdTe quantum dots. Resultant anti-NBEAL1 antibody-conjugated nanoprobes were injected into mice via tail vessel. After 12h, it is clearly observed that prepared nanoprobes located in brain tissues of mice model with glioma by IVIS Imaging system. In conclusion, NBEAL1 protein was successfully expressed and its monoclonal antibody was successfully prepared. Anti-NBEAL1 antibody-conjugated quantum dots may be used to image glioma. These prepared nanoprobes have great potential in early detection of glioma.

References

[1]

Schwartzbaum JA, Fisher JL, Aldape KD, Wrensch M. Epidemiology and molecular pathology of glioma. Nat Clin Pract Neuro 2006; 2: 494-503. doi: 10.1038/ncpneuro0289

[2]

Lu C, Shervington A. Chemoresistance in gliomas. Mol Cell Biochem 2008; 312: 71-80. doi: 10.1007/s11010-008-9722-8

[3]

Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, Cavenee WK. The WHO classification of tumors of the nervous system. J Neuropath Exp Neur 2002; 61: 215.

[4]
Louis DN, Ohgaki H, Wiestler OD, Cavenee WK. WHO classification of tumours of the central nervous system: International Agency for Research on Cancer Lyon, France, 2007.
[5]

Louis DN, Ohgaki H, Wiestler OD, Cavenee WK. Burger PC, Jouvet A, Scheithauer BW, Kleihues P. The 2007 WHO classification of tumours of the central nervous system. Acta neuropathologica 2007; 114: 97-109

[6]

Martin-Villalba A, Okuducu AF, von Deimling A. The evolution of our understanding on glioma. Brain Pathology 2008; 18: 455-463. doi: 10.1111/j.1750-3639.2008.00136.x

[7]

Nakada M, Nakada S, Demuth T, Tran NL, Hoelzinger DB, Berens ME. Molecular targets of glioma invasion. Cell Mol Life Sci 2007; 64: 458-478. doi: 10.1007/s00018-007-6342-5

[8]

Grier JT, Batchelor T. Low-grade gliomas in adults. The Oncologist 2006; 11: 681. doi: 10.1634/theoncologist.11-6-681

[9]

McKnight TR, von dem Bussche MH, Vigneron DB, Lu Y, Berger MS, McDermott MW. Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence. J Neurosurg 2002; 97: 794-802. doi: 10.3171/jns.2002.97.4.0794

[10]

Galanaud D, Chinot O, Nicoli F, Confort-Gouny S, Le Fur Y, Barri Attarian M, Ranjeva JP, Fuent S, Viout P, Figarella-Branger D. Use of proton magnetic resonance spectroscopy of the brain to differentiate gliomatosis cerebri from low-grade glioma. J Nneurosurg 2003; 98: 269-276. doi: 10.3171/jns.2003.98.2.0269

[11]

Jeuken JWM, Deimling AV, Wesseling P. Molecular pathogenesis of oligodendroglial tumors. J Neuro-oncol 2004; 70: 161-181. doi: 10.1007/s11060-004-2748-1

[12]

Chen J, Lu Y, Xu J, Huang Y, Cheng H, Hu G, Luo C, Lou M, Cao G, Xie Y, Ying K. Identification and characterization of NBEAL1, a novel human neurobeachin-like 1 protein gene from fetal brain, which is up regulated in glioma. Brain Res Mol Brain Res 2004; 125: 147-155. doi: 10.1016/j.molbrainres.2004.02.022

[13]

Jeong H, Chang AM and Melloch MR. The Kondo Effect in an Artificial Quantum Dot Molecule. Science 2001; 293: 2221-2223. doi: 10.1126/science.1063182

[14]

Li XQ, Wu YW, Steel D, Gammon D, Stievater TH, Katzer DS. An all-optical quantum gate in a semiconductor quantum dot. Science 2003; 301: 809-811. doi: 10.1126/science.1083800

[15]

Lu W, Ji ZQ, Pfeiffer L, West KW, Rimberg AJ. Realtime detection of electron tunnelling in a quantum dot. Nature 2003; 423: 422-425. doi: 10.1038/nature01642

[16]

You X, He R, Gao F, Shao J, Pan B, Cui D. Preparation and characterization of CdTe@SiO2 core/shell luminescent composite nano particles. Acta Chimi Sin 2007; 65: 561-565.

[17]

Kaul Z, Yaguchi T, Kaul SC, Hirano T, Wadhwa R and Taira K. Mortalin imaging in normal and cancer cells with quantum dot immuno-conjugates. Cell Res 2003; 13: 503-507. doi: 10.1038/sj.cr.7290194

[18]

Medintz IL, Uyeda HT, Goldman ER and Mattoussi H. Quantum dot bioconjugates for imaging, labelling and sensing. Nature Mater 2005; 4: 435-446. doi: 10.1038/nmat1390

[19]

Shao J, You X, Gao F, He R, Cui D. Labeling of quantum dots with streptavidin and its bioactivity measurement. Chinese J Anal Chem 2006; 34: 1625-1628.

[20]

He R, You X, Shao J, Gao F, Pan B, Cui D. Core/shell fluorescent magnetic silica-coated composite nanoparticles for bioconjugation. Nanotechnology 2007; 18, 315601. doi: 10.1088/0957-4484/18/31/315601

[21]

Cui D. Pan B. Zhang H, Wu R, Wang J, Asahi T, et al. Self/Assembly of Quantum Dots and Carbon Nanotubes For Ultrasensitive DNA and Antigen Detection. Anal Chem 2008; 80: 7996-8001. doi: 10.1021/ac800992m

[22]

Li Z, Huang P, He R, Lin J, Yang S, Zhang X, et al. Aptamer-conjugated dendrimer-modified quantum dots for cancer cell targeting and imaging. Mater Lett 2010; 64: 375-378. doi: 10.1016/j.matlet.2009.11.022

[23]

Cui D, Gao T, Jin D, Sun T, Tian F, Estrada GG, et al. Characterization of BRCAA1 and its clinical significance. Cancer Epid. Biomarker Prev 2004; 13: 1336-1445.

[24]

Jogl G, Shen Y, Gebauer D, Li J, Wiegmann K, Kashkar H, Kroke M, et al. Crystal structure of the BEACH domain reveals an unusual fold and extensive association with a novel PH domain. EMBO J 2002; 21: 4785-4795. doi: 10.1093/emboj/cdf502

[25]

De Lozanne A. The Role of BEACH Proteins in Dictyostelium. Traffic 2003; 4: 6. doi: 10.1034/j.1600-0854.2003.40102.x

[26]

Su Y, Balice-Gordon RJ, Hess DM, Landsman DS, Minarcik J, Golden J, et al. Neurobeachin is essential for neuromuscular synaptic transmission. J Neurosci 2004; 24: 3627-3636. doi: 10.1523/JNEUROSCI.4644-03.2004

[27]

Wang X, Herberg FW, Laue MM, Wullner C, Hu B, Petrasch-Parwez E, et al. Neurobeachin: A protein kinase A-anchoring, beige/Chediak-higashi protein homolog implicated in neuronal membrane traffic. J Neurosci 2000; 20: 8551-8565.

[28]

O'Neal J, Gao F, Hassan A, Monahan R, Barrios S, Lee I, et al. Neurobeachin (NBEA) is a target of recurrent interstitial deletions at 13q13 in patients with MGUS and multiple myeloma. Exp Hematol 2009; 37: 234-244. doi: 10.1016/j.exphem.2008.10.014

[29]

Yip S, Iafrate AJ, Louis DN. Molecular Diagnostic Testing in Malignant Gliomas: A Practical Update on Predictive Markers. J Neuropathol Exp Neurol 2008; 67: 1-15. doi: 10.1097/nen.0b013e31815f65fb

[30]

Hesson LB, Krex D, Latif F. Epigenetic markers in human gliomas: prospects for therapeutic intervention. Expert Rev Neurother 2008, 8, 1475-1496. doi: 10.1586/14737175.8.10.1475

[31]

Pc B, Schthauer BW, Vogel FS. Surgical Pathology of the Nervous System and its coverings. Philadelphia: churchill Livingstone, 2002.

Nano Biomedicine and Engineering
Pages 50-56
Cite this article:
Bao C, Yang H, Sheng P, et al. Cloning, Expression, Monoclonal Antibody Preparation of Human Gene NBEAL1 and Its Application in Targeted Imaging of Mouse Glioma. Nano Biomedicine and Engineering, 2009, 1(1): 50-56. https://doi.org/10.5101/nbe.v1i1.p50-56

311

Views

2

Downloads

1

Crossref

7

Scopus

Altmetrics

Received: 10 November 2009
Accepted: 06 December 2009
Published: 09 December 2009
© 2009 Chenchen Bao et al.

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited

Return